BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 15153616)

  • 1. Behavioral changes in unilaterally 6-hydroxy-dopamine lesioned rats after transplantation of differentiated mouse embryonic stem cells without morphological integration.
    Baier PC; Schindehütte J; Thinyane K; Flügge G; Fuchs E; Mansouri A; Paulus W; Gruss P; Trenkwalder C
    Stem Cells; 2004; 22(3):396-404. PubMed ID: 15153616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fate of pre-differentiated mouse embryonic stem cells transplanted in unilaterally 6-hydroxydopamine lesioned rats: histological characterization of the grafted cells.
    Thinyane K; Baier PC; Schindehütte J; Mansouri A; Paulus W; Trenkwalder C; Flügge G; Fuchs E
    Brain Res; 2005 May; 1045(1-2):80-7. PubMed ID: 15910765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental cue-dependent dopaminergic neuronal differentiation and functional effect of grafted neuroepithelial stem cells in parkinsonian brain.
    Mine Y; Hayashi T; Yamada M; Okano H; Kawase T
    Neurosurgery; 2009 Oct; 65(4):741-53; discussion 753. PubMed ID: 19834380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesencephalic neural stem (progenitor) cells develop to dopaminergic neurons more strongly in dopamine-depleted striatum than in intact striatum.
    Nishino H; Hida H; Takei N; Kumazaki M; Nakajima K; Baba H
    Exp Neurol; 2000 Jul; 164(1):209-14. PubMed ID: 10877931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation of immortalized mesencephalic progenitors (CSM14.1 cells) into the neonatal parkinsonian rat caudate putamen.
    Haas SJ; Beckmann S; Petrov S; Andressen C; Wree A; Schmitt O
    J Neurosci Res; 2007 Mar; 85(4):778-86. PubMed ID: 17203489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential use of embryonic stem cells for the treatment of mouse parkinsonian models: improved behavior by transplantation of in vitro differentiated dopaminergic neurons from embryonic stem cells.
    Nishimura F; Yoshikawa M; Kanda S; Nonaka M; Yokota H; Shiroi A; Nakase H; Hirabayashi H; Ouji Y; Birumachi J; Ishizaka S; Sakaki T
    Stem Cells; 2003; 21(2):171-80. PubMed ID: 12634413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of mouse embryonic stem cell-derived neurons into the striatum, subthalamic nucleus and substantia nigra, and behavioral recovery in hemiparkinsonian rats.
    Inden M; Kim DH; Qi M; Kitamura Y; Yanagisawa D; Nishimura K; Tsuchiya D; Takata K; Hayashi K; Taniguchi T; Yoshimoto K; Shimohama S; Sumi S; Inoue K
    Neurosci Lett; 2005 Oct; 387(3):151-6. PubMed ID: 16023291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor-20 promotes the differentiation of Nurr1-overexpressing neural stem cells into tyrosine hydroxylase-positive neurons.
    Grothe C; Timmer M; Scholz T; Winkler C; Nikkhah G; Claus P; Itoh N; Arenas E
    Neurobiol Dis; 2004 Nov; 17(2):163-70. PubMed ID: 15474354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease.
    Carvey PM; Ling ZD; Sortwell CE; Pitzer MR; McGuire SO; Storch A; Collier TJ
    Exp Neurol; 2001 Sep; 171(1):98-108. PubMed ID: 11520124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal conditions for in vivo induction of dopaminergic neurons from embryonic stem cells through stromal cell-derived inducing activity.
    Morizane A; Takahashi J; Takagi Y; Sasai Y; Hashimoto N
    J Neurosci Res; 2002 Sep; 69(6):934-9. PubMed ID: 12205686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.
    Collier TJ; Sortwell CE; Elsworth JD; Taylor JR; Roth RH; Sladek JR; Redmond DE
    J Comp Neurol; 2002 Jan; 442(4):320-30. PubMed ID: 11793337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors.
    Glavaski-Joksimovic A; Virag T; Chang QA; West NC; Mangatu TA; McGrogan MP; Dugich-Djordjevic M; Bohn MC
    Cell Transplant; 2009; 18(7):801-14. PubMed ID: 19796495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of transplantable dopamine neuron precursors at different stages of midbrain neurogenesis.
    Jönsson ME; Ono Y; Björklund A; Thompson LH
    Exp Neurol; 2009 Sep; 219(1):341-54. PubMed ID: 19555687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesencephalic human neural progenitor cells transplanted into the adult hemiparkinsonian rat striatum lack dopaminergic differentiation but improve motor behavior.
    Hovakimyan M; Haas SJ; Schmitt O; Gerber B; Wree A; Andressen C
    Cells Tissues Organs; 2008; 188(4):373-83. PubMed ID: 18560206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival and early functional integration of dopaminergic progenitor cells following transplantation in a rat model of Parkinson's disease.
    Hahn M; Timmer M; Nikkhah G
    J Neurosci Res; 2009 Jul; 87(9):2006-19. PubMed ID: 19235889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in vitro interval before transplantation of mesencephalic reaggregates does not compromise survival or functionality.
    Sortwell CE; Collier TJ; Camargo MD; Pitzer MR
    Exp Neurol; 2004 May; 187(1):58-64. PubMed ID: 15081588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-transplantation of carotid body and ventral mesencephalic cells as an alternative approach towards functional restoration in 6-hydroxydopamine-lesioned rats: implications for Parkinson's disease.
    Shukla S; Agrawal AK; Chaturvedi RK; Seth K; Srivastava N; Sinha C; Shukla Y; Khanna VK; Seth PK
    J Neurochem; 2004 Oct; 91(2):274-84. PubMed ID: 15447661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease.
    Höglinger GU; Widmer HR; Spenger C; Meyer M; Seiler RW; Oertel WH; Sautter J
    Exp Neurol; 2001 Jan; 167(1):148-57. PubMed ID: 11161602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantation of pure cultured olfactory ensheathing cells in an animal model of parkinsonism.
    Dewar D; Bentley D; Barnett SC
    Acta Neurochir (Wien); 2007; 149(4):407-14. PubMed ID: 17380250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrastriatal and intranigral grafting of hNT neurons in the 6-OHDA rat model of Parkinson's disease.
    Baker KA; Hong M; Sadi D; Mendez I
    Exp Neurol; 2000 Apr; 162(2):350-60. PubMed ID: 10739641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.